Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01513499 · ClinicalTrials.gov registry record · Early Phase 1
Effect of Intranasal Oxytocin on Appetite and Caloric Intake in Men and Women
A Early Phase 1 study of Eating Behavior, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT01513499 is a Early Phase 1 study of Eating Behavior that has completed, run by Massachusetts General Hospital. The registered enrollment target is 25 participants, below the 175-participant average among 20 other Eating Behavior trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01513499, a Early Phase 1 study of Eating Behavior, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Exciting advances have led to the concept that hormones can modulate appetite and food intake. Oxytocin is a peptide hormone that is released in regions throughout the brain, including areas involved in food motivation. Animal studies suggest that oxytocin may reduce food intake. The effects of oxytocin administration on eating behavior in humans, which could have important implications in eating-related disorders ranging from obesity to anorexia nervosa, have not been investigated. This double-blind placebo-controlled cross-over study of single-dose oxytocin administration investigates whether: 1. Caloric intake will decrease following administration of oxytocin versus placebo 2. Appetite will decrease following administration of oxytocin versus placebo 3. Resting energy expenditure will increase following administration of oxytocin versus placebo
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Oxytocin
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2012-01 |
| Est. Completion | 2014-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01513499
The ClinicalTrials.gov registry entry for NCT01513499 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 175-participant average among 20 other Eating Behavior trials with a reported enrollment target (86% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eating Behavior appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01513499 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01513499 about?
NCT01513499 is a clinical study titled "Effect of Intranasal Oxytocin on Appetite and Caloric Intake in Men and Women". Exciting advances have led to the concept that hormones can modulate appetite and food intake. Oxytocin is a peptide hormone that is released in regions throughout the brain, including areas involved in food motivation. Animal studies suggest that oxytocin may reduce food intake. The effects of oxyt...
What is the current status of trial NCT01513499?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 25 participants. The study started on 2012-01. Estimated completion is 2014-01.
What conditions does trial NCT01513499 study?
This clinical trial studies the following conditions: Eating Behavior.
What interventions are being tested in trial NCT01513499?
The interventions under investigation include: Placebo (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT01513499?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01513499 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eating Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Interoception and Eating Behaviors in Children
RECRUITING
-
Mother-Baby Study - Caloric Compensation Index (COMPX)
RECRUITING · NA
-
Food for Thought: Executive Functioning Around Eating Among Children
RECRUITING · NA
-
Mother-Baby Study - Relative Reinforcing Value (RRV)
RECRUITING · NA
-
Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women
RECRUITING · NA
-
Mother-Baby Study - Eating in the Absence of Hunger (EAH)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.